Skip to content

Price / book at other companies

Johnson & Johnson logo
Johnson & JohnsonJNJ
7.3×+2.1×
Medtronic logo
MedtronicMDT
2.1×-0.1×
Intuitive Surgical logo
Intuitive SurgicalISRG
9.4×-1.0×

Other financials

Income statement

See full
Revenue$2.1B+9.3%
Gross profit$1.5B+11.1%
Operating income$373.2M+27.7%
Net income$238.1M+30.8%
EPS (diluted)$1.22+34.1%

Balance sheet

See full
Cash & equivalents$424.2M-69.4%
Total debt$7.5B+4.1%
Total equity$12.7B+2.2%
Total assets$22.7B+2.4%

Cash flow

See full
Operating cash flow$359.4M-6.1%
CapEx$36.3M-18.6%
Free cash flow$323.1M-4.5%

Valuation

See full
Market cap$17.02B-21.5%
Enterprise value$24.07B-12.7%
P/E22.4×-1.4×
P/S-0.8×

Profitability

See full
Gross margin70%-1.0pp
Operating margin14%-3.0pp
Net margin9.1%-2.8pp

Returns & leverage

See full
Return on equity6.1%-1.2pp
Debt / equity0.6×0.0×
Current ratio1.7×-0.7×

Where this comes from

Calculated from Zimmer Biomet Holdings’s reported figures.

Based on the most recent quarter.

The official record: Zimmer Biomet Holdings’s 10-Q, filed May 1, 2026, on SEC EDGAR. View the filing →

Ask your AI about Zimmer Biomet Holdings's price / book.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Zimmer Biomet Holdings's price / book?
Zimmer Biomet Holdings (ZBH) reported price / book of 1.4× in Q1 2026.
How has Zimmer Biomet Holdings's price / book changed year-over-year?
Zimmer Biomet Holdings's price / book decreased by 23.2% year-over-year, from 1.8× to 1.4×.
What is the long-term trend for Zimmer Biomet Holdings's price / book?
Over 4 years (2021 to 2025), Zimmer Biomet Holdings's price / book has grown at a -10.3% compound annual growth rate (CAGR), from 9.6× to 6.2×.
What does price / book mean?
How the market price compares to the company's accounting net worth.
How do you interpret price / book?
Below 1.0 can flag a market discount to book value (common for distressed or asset-heavy firms); high values reflect intangible value the balance sheet doesn't capture. Most informative for financials and asset-heavy businesses.
How does price / book compare across companies?
A core valuation gauge for banks and insurers; weak for asset-light firms where book value understates economic value.